Show
Sort by
-
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP
-
Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD
-
- Journal Article
- A1
- open access
Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma
-
Dupilumab improves sense of smell and reduces anosmia among patients with nasal polyposis and chronic sinusitis : results from a phase 2a trial
-
Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma : results from a phase 2a trial